Quantifying Real-world Effectiveness of Mental Health Interventions for Suicide Prevention in At-risk Adolescent and Transitional Age Youth

量化高危青少年和过渡时期青年心理健康干预措施预防自杀的现实有效性

基本信息

  • 批准号:
    10394352
  • 负责人:
  • 金额:
    $ 29.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-01 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY AND ABSTRACT – Cambridge Health Alliance ALACRITY for Early Screening and Treatment of High Risk Youth (eSToRY) R34 - Quantifying real-world effectiveness of mental health interventions for suicide prevention in at- risk adolescent and transitional age youth Identifying effective suicide prevention strategies for racial/ethnic and language (REL)-diverse populations of youth at high risk of suicide has enormous public health importance. Suicide rates for persons aged 10–24 have increased by more than 50% over the last decade in nearly every state and for nearly every racial/ethnic minority group, with particularly concerning increases in suicide attempts among Black youth. In this project, we utilize a unique clinical-sociocontextual dataset of over 15,000 youth patients at high risk for suicide to conduct high-dimensional comparative effectiveness research (CER) of community-based mental health interventions in the prevention of self-injurious thoughts and behaviors among REL-diverse adolescents and transitional age youth. We leverage an enormous warehouse of clinical, insurance, criminal justice, individual- and neighborhood-level social determinants of health data to multi-dimensionally match treatment and control groups and assess the impact of differing community-based treatment regimes on suicidal outcomes. In Aim 1, we propose innovative comparative effectiveness research using a large retrospective clinical- sociocontextual dataset to identify effective treatments for suicide prevention, and how these differ across REL-diverse groups. In Aim 2, we identify a sub-sample of this cohort in the present day, following up our retrospective analysis with a computerized adaptive test analyzing current day suicidal outcomes, psychopathology, and measures social determinants of health and quality of care. This will allow for assessment of long-run treatment outcomes, and how unobserved variables may bias comparative effectiveness research results. This study lays the groundwork for two R01-level studies: 1) a larger CER trial of treatment regimes across multiple institutions; and 2) a sequential multiple assignment randomized trial (SMART) that evaluates the impact of systematic adaptation of treatment on suicide outcomes. The project will contribute to a better understanding of whether, how, when, and for whom to alter the duration, frequency, type, or delivery of treatments at pivotal steps in the episode of treatment, leading to interventions that will reduce the risk of suicidality in vulnerable REL-diverse populations.
项目摘要和摘要 - 剑桥健康联盟 早期筛查和治疗高风险青年(Estory)的痛苦 R34-量化心理健康干预措施对预防自杀的现实有效性 风险青少年和过渡年龄青年 确定有效的种族/种族和语言预防自杀策略(rel) 自杀风险高的青年具有巨大的公共健康重要性。 10-24岁的人的自杀率 在过去的十年中,几乎每个州和几乎每个种族/种族都增加了50%以上 少数群体尤其是关于黑人青年自杀企图的增加。在这个项目中, 我们利用了15,000名自杀风险高的青年患者的独特临床秘密文化数据集 对基于社区的心理健康进行高维比较有效性研究(CER) 涉嫌预防自治的思想和行为的干预措施 过渡年龄青年。我们利用临床,保险,刑事司法,个人的巨大仓库 以及邻里级别的健康数据社会决定者,以匹配多维的治疗和控制 小组并评估区分基于社区的治疗方案对自杀结果的影响。 在AIM 1中,我们提出了使用大型回顾性临床 - 社会上下文数据集,以识别预防自杀的有效治疗方法,以及它们之间的不同 回生多样性群体。 在AIM 2中,我们确定了当今该队列的一个子样本,跟随我们的回顾性分析 计算机化自适应测试分析了当前自杀结果,心理病理学和衡量社会 健康和护理质量的决定因素。这将允许评估长期治疗结果,并 未观察到的变量如何偏向比较有效性研究结果。 这项研究为两项R01级研究奠定了基础:1)跨越跨越治疗方案的CER试验 多个机构; 2)评估评估 系统适应治疗对自杀预后的影响。该项目将有助于更好 了解是否,如何,何时以及为谁改变持续时间,频率,类型或交付 治疗情节中关键步骤的治疗,导致干预措施将降低 弱势群体人群中的自杀性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Philip S Wang的其他基金

Quantifying Real-world Effectiveness of Mental Health Interventions for Suicide Prevention in At-risk Adolescent and Transitional Age Youth
量化高危青少年和过渡时期青年心理健康干预措施预防自杀的现实有效性
  • 批准号:
    10610840
    10610840
  • 财政年份:
    2021
  • 资助金额:
    $ 29.53万
    $ 29.53万
  • 项目类别:
Quantifying Real-world Effectiveness of Mental Health Interventions for Suicide Prevention in At-risk Adolescent and Transitional Age Youth
量化高危青少年和过渡时期青年心理健康干预措施预防自杀的现实有效性
  • 批准号:
    10205663
    10205663
  • 财政年份:
    2021
  • 资助金额:
    $ 29.53万
    $ 29.53万
  • 项目类别:
Remibursement Limits, Antidepressants, and Outcomes
报销限额、抗抑郁药和结果
  • 批准号:
    6718694
    6718694
  • 财政年份:
    2004
  • 资助金额:
    $ 29.53万
    $ 29.53万
  • 项目类别:
Remibursement Limits, Antidepressants, and Outcomes
报销限额、抗抑郁药和结果
  • 批准号:
    6850814
    6850814
  • 财政年份:
    2004
  • 资助金额:
    $ 29.53万
    $ 29.53万
  • 项目类别:
Outreach and Treatment for Depression in the Labor Force
劳动力抑郁症的推广和治疗
  • 批准号:
    6663102
    6663102
  • 财政年份:
    2002
  • 资助金额:
    $ 29.53万
    $ 29.53万
  • 项目类别:
Outreach and Treatment for Depression in the Labor Force
劳动力抑郁症的推广和治疗
  • 批准号:
    6475182
    6475182
  • 财政年份:
    2002
  • 资助金额:
    $ 29.53万
    $ 29.53万
  • 项目类别:
Outreach and Treatment for Depression in the Labor Force
劳动力抑郁症的推广和治疗
  • 批准号:
    6798251
    6798251
  • 财政年份:
    2002
  • 资助金额:
    $ 29.53万
    $ 29.53万
  • 项目类别:
APPROPRIATENESS AND COMPLIANCE IN DEPRESSION TREATMENT
抑郁症治疗的适当性和依从性
  • 批准号:
    6165127
    6165127
  • 财政年份:
    1999
  • 资助金额:
    $ 29.53万
    $ 29.53万
  • 项目类别:
APPROPRIATENESS AND COMPLIANCE IN DEPRESSION TREATMENT
抑郁症治疗的适当性和依从性
  • 批准号:
    6637561
    6637561
  • 财政年份:
    1999
  • 资助金额:
    $ 29.53万
    $ 29.53万
  • 项目类别:
APPROPRIATENESS AND COMPLIANCE IN DEPRESSION TREATMENT
抑郁症治疗的适当性和依从性
  • 批准号:
    6530804
    6530804
  • 财政年份:
    1999
  • 资助金额:
    $ 29.53万
    $ 29.53万
  • 项目类别:

相似海外基金

RP4 LEAP
RP4飞跃
  • 批准号:
    10595904
    10595904
  • 财政年份:
    2023
  • 资助金额:
    $ 29.53万
    $ 29.53万
  • 项目类别:
RP5 MPT Study
RP5 MPT 研究
  • 批准号:
    10595905
    10595905
  • 财政年份:
    2023
  • 资助金额:
    $ 29.53万
    $ 29.53万
  • 项目类别:
Mechanisms of accelerated calcification and structural degeneration of implantable biomaterials in pediatric cardiac surgery
小儿心脏手术中植入生物材料加速钙化和结构退化的机制
  • 批准号:
    10655959
    10655959
  • 财政年份:
    2023
  • 资助金额:
    $ 29.53万
    $ 29.53万
  • 项目类别:
Strategies to Achieve Viral Suppression for Youth with HIV (The SAVVY Study)
青少年艾滋病病毒感染者实现病毒抑制的策略(SAVVY 研究)
  • 批准号:
    10762109
    10762109
  • 财政年份:
    2023
  • 资助金额:
    $ 29.53万
    $ 29.53万
  • 项目类别:
Impact of cannabis legalization on prescription drug use and health outcomes in Connecticut
大麻合法化对康涅狄格州处方药使用和健康结果的影响
  • 批准号:
    10576002
    10576002
  • 财政年份:
    2023
  • 资助金额:
    $ 29.53万
    $ 29.53万
  • 项目类别: